Nosocomial diarrhoea due to Clostridium difficile

Current Opinion in Infectious Diseases
T V Riley

Abstract

The purpose of this review is to summarize recent developments in the diagnosis, epidemiology, treatment and prevention of nosocomial diarrhoea due to Clostridium difficile. Twenty-five years after its discovery, the diagnosis of C. difficile-associated diarrhoea is still problematic with laboratories trying to reconcile the time and expense of the diagnostic process. Newer molecular techniques may offer hope. With the introduction of new antibiotics into clinical practice, confusion has arisen about the risk they pose for C. difficile-associated diarrhoea. Strains of C. difficile that fail to produce an active toxin A are an emerging problem and good molecular epidemiology is required to determine whether highly infectious clones exist. Little progress has been made in the treatment of recurrent C. difficile-associated diarrhoea; however, the development of a vaccine is imminent. More effort is being made to rid the hospital environment of C. difficile through infection-control procedures or changes in antibiotic-prescribing policies. C. difficile continues to be a major nosocomial infection in many health-care institutions throughout the world. Strategies that reduce exposure to the organism or to antibiotics will have an imp...Continue Reading

References

May 20, 1978·Lancet·H E LarsonS P Borriello
Dec 1, 1977·The Journal of Infectious Diseases·W L GeorgeS M Finegold
Aug 1, 1992·The Journal of Antimicrobial Chemotherapy·C L GolledgeT V Riley
Sep 1, 1996·The Journal of Hospital Infection·M H WilcoxC Redpath
Mar 24, 1998·Annual Review of Medicine·C P Kelly, J T LaMont
Feb 10, 2000·The New England Journal of Medicine·L KyneC P Kelly
Oct 10, 2001·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J S Brazier
Dec 10, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Claudia ThomasThomas V Riley
Dec 24, 2002·The Journal of Hospital Infection·S M MeakinsS J O'Brien
Feb 8, 2003·Journal of Clinical Microbiology·Tracy D Wilkins, David M Lyerly
Feb 8, 2003·Journal of Clinical Microbiology·Simon D BélangerMichel G Bergeron
Feb 21, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Johannes AasJohan S Bakken
Feb 22, 2003·Infection and Immunity·Samer AboudolaCiarán P Kelly
Mar 18, 2003·The Annals of Pharmacotherapy·Juan Ortiz-de-SarachoRamiro López
Apr 19, 2003·Journal of Clinical Microbiology·Stuart JohnsonDale N Gerding
May 24, 2003·Best Practice & Research. Clinical Gastroenterology·Mark H Wilcox
Jun 5, 2003·Emerging Infectious Diseases·Margaret E McCuskerMary-Claire Roghmann
Jun 7, 2003·Journal of Clinical Microbiology·Patrizia Spigaglia, Paola Mastrantonio
Jul 12, 2003·The Journal of Hospital Infection·R CunninghamN Gaunt

❮ Previous
Next ❯

Citations

Mar 10, 2009·Médecine et maladies infectieuses·E K ErgenE J Kuijper
Jul 16, 2013·Applied and Environmental Microbiology·Daniel R Knight, Thomas V Riley
Dec 7, 2007·International Journal of Hematology·Bulent AliogluNamik Ozbek
May 11, 2006·The Annals of Pharmacotherapy·Kevin W GareyHerbert L Dupont
Jun 19, 2015·Clinical Microbiology Reviews·Daniel R KnightThomas V Riley
Apr 6, 2006·Journal of Medical Microbiology·Luis G ArroyoJ Scott Weese
Aug 9, 2006·The Medical Journal of Australia·Thomas V Riley

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.